| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/09/2003 | US20030008002 Containing titanium dioxide platelets |
| 01/09/2003 | US20030007994 Releasing estrogen and cyclodextrin |
| 01/09/2003 | US20030007992 Zero-order prolonged release coaxial implants |
| 01/09/2003 | US20030007963 Treatment of pompe's disease |
| 01/09/2003 | US20030007960 Oral administering of protein as protease inhibitor; rheumatic diseases |
| 01/09/2003 | US20030007959 Oral methods of treatment |
| 01/09/2003 | US20030007958 Mixture of silica, flow control agent and carrier; cyclooxygenase inhibitor, antiinflammatory agents |
| 01/09/2003 | US20030007954 Cardiovascular disorder; strokes; gene therapy |
| 01/09/2003 | US20030007944 Spraying skins; mixture containing polyurethane binder |
| 01/09/2003 | US20030007934 Delivery of stimulants through an inhalation route |
| 01/09/2003 | US20030007933 Delivery of muscle relaxants through an inhalation route |
| 01/09/2003 | US20030007932 Drug delivery; overcoated solid dried active solid |
| 01/09/2003 | US20030005927 Process and device for inhalation of particulate medicaments |
| 01/09/2003 | US20030005925 Delivery of rizatriptan or zolmitriptan through an inhalation route |
| 01/09/2003 | US20030005924 Delivery of beta-blockers through an inhalation route |
| 01/09/2003 | CA2452364A1 Stabilized formulations of interferons with sulfoalkyl ether cyclodextrins |
| 01/09/2003 | CA2452030A1 Sustained release pharmaceutical composition |
| 01/09/2003 | CA2451816A1 Intradermal delivery of vaccines and gene therapeutic agents via microcannula |
| 01/09/2003 | CA2451739A1 Hcv e1e2 vaccine compositions |
| 01/09/2003 | CA2451317A1 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 01/09/2003 | CA2451236A1 Peptides for use as translocation factors |
| 01/09/2003 | CA2451195A1 Antitumoral formulations of thioxanthenone |
| 01/08/2003 | EP1273308A1 Peptide-flavonoid conjugates, their preparation and use in uv protection |
| 01/08/2003 | EP1273301A2 Pharmaceutical preparations based on active ingredients susceptible to illicit administration |
| 01/08/2003 | EP1273300A2 A stable external preparation containing aspirin |
| 01/08/2003 | EP1273299A1 Minoxidil-containing preparations |
| 01/08/2003 | EP1273294A1 Fenofibrate pharmaceutical composition with a higher bioavailability and its manufacturing process |
| 01/08/2003 | EP1273293A1 Fenofibrate suspension in a hydrophilic polymer solution |
| 01/08/2003 | EP1273292A1 Optimised formulation of tobramycin for aerosolization |
| 01/08/2003 | EP1273289A1 Pharmaceutical compositions containing ascomycin derivatives |
| 01/08/2003 | EP1273288A1 Pharmaceutical compositions containing rapamycin derivatives |
| 01/08/2003 | EP1273284A2 High SPF nontacky/nongreasy UV-photoprotecting compositions comprising particulates of MMA crosspolymers |
| 01/08/2003 | EP1272665A1 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 01/08/2003 | EP1272653A2 Methods for ansamitocin production |
| 01/08/2003 | EP1272531A2 Crystalline mixtures of partial methyl ethers of beta-cyclodextrin and related compounds |
| 01/08/2003 | EP1272530A1 Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals |
| 01/08/2003 | EP1272509A2 Prion-binding peptidic ligands and methods of using same |
| 01/08/2003 | EP1272470A1 Amorphous torasemide modification |
| 01/08/2003 | EP1272230A1 An injectable bone mineral substitute material |
| 01/08/2003 | EP1272225A2 Lipid-based systems for targeting diagnostic agents |
| 01/08/2003 | EP1272223A1 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same |
| 01/08/2003 | EP1272222A2 Compositions for drug delivery |
| 01/08/2003 | EP1272221A2 Peptide conjugates for drug delivery |
| 01/08/2003 | EP1272184A2 Pharmaceutical compositions comprising salmeterol and ipratropium |
| 01/08/2003 | EP1272183A1 Methods and compositions useful in enhancing oxygen delivery to cells |
| 01/08/2003 | EP1272180A1 Concentrated solutions of carvedilol |
| 01/08/2003 | EP1272179A1 Hydrophilic molecular disperse solutions of carvedilol |
| 01/08/2003 | EP1272177A1 Method and formulation for treating resistance to antihypertensives and related conditions |
| 01/08/2003 | EP1272169A2 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| 01/08/2003 | EP1272167A1 Hydrophilic/lipophilic polymeric matrix dosage formulation |
| 01/08/2003 | EP1272166A2 Pharmaceutical compositions comprising fluvastatin |
| 01/08/2003 | EP1272165A1 Acrylic enteric coating compositions |
| 01/08/2003 | EP1272163A2 Pharmaceutical compositions |
| 01/08/2003 | EP1272162A1 Stabilized dry powder formulations |
| 01/08/2003 | EP1272161A2 Lipid-based drug delivery systems against parasitic infections |
| 01/08/2003 | EP1272160A2 Lipid-based drug delivery systems for topical application |
| 01/08/2003 | EP1272157A2 Topical micronutrient delivery system and uses thereof |
| 01/08/2003 | EP1272059A2 Method of producing oily suspensions of water-soluble vitamins |
| 01/08/2003 | EP1272044A1 Protein stabilised emulsions |
| 01/08/2003 | EP1124594B1 Implant with cavities containing therapeutic agents |
| 01/08/2003 | EP1098665B1 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 01/08/2003 | EP1021192B1 Dexamethasone gel |
| 01/08/2003 | EP1009439B1 Polymer-platinum compounds |
| 01/08/2003 | EP0981375B1 Pharmaceutical compositions containing plasma protein |
| 01/08/2003 | EP0906107B1 Compositions comprising vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs |
| 01/08/2003 | CN1390257A Transfer compounds, the production and the use thereof |
| 01/08/2003 | CN1390227A Enzyme catalyzed therapeutic activation |
| 01/08/2003 | CN1390143A Amphiphilic prodrugs |
| 01/08/2003 | CN1390142A Taxane prodrugs |
| 01/08/2003 | CN1390141A Nucleic acid-containing complex |
| 01/08/2003 | CN1390140A Method for linking molecular substances |
| 01/08/2003 | CN1390135A Topical treatment of streptococcal infections |
| 01/08/2003 | CN1390132A Use of pegylated interferon alpha in melanoma therapy |
| 01/08/2003 | CN1390127A Antifungal oral composition containing itraconazole and process for preparing same |
| 01/08/2003 | CN1390125A High lipid diet |
| 01/08/2003 | CN1390121A Morphine sulphate microgranules, method for preparing same and compositions containing same |
| 01/08/2003 | CN1390120A Compression molded product and production method therefor |
| 01/08/2003 | CN1390119A Process for making aqueous coated beadlets |
| 01/08/2003 | CN1390118A Dextrose and insulin fluid formulation for intravenous infusion |
| 01/08/2003 | CN1390091A Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and composition containing the same |
| 01/08/2003 | CN1389470A Stabilizer for recombinant alpha-interferon liquid |
| 01/08/2003 | CN1389211A Puerarin injection and its prepn. process |
| 01/08/2003 | CN1389206A Cataract-resisting eye medicament and the ophthalmic application of corneal osmosis promoter azone |
| 01/08/2003 | CN1098344C Substantially linear ethylene/alpha-olefin polymers as viscosity index improvers or gelling agents |
| 01/08/2003 | CN1098106C Anthracycline conjugates, their preparation and their use as antitumor agents |
| 01/08/2003 | CN1098105C Biodegradable sustained release preparation for treating periodontitis |
| 01/08/2003 | CN1098103C Pharmaceutical use of sympathetic human white-cell interferon |
| 01/08/2003 | CN1098074C Topical ketoconazole emulsions |
| 01/08/2003 | CN1098068C Container with multi-phase composition for use in diagnostic and therapeutic applications |
| 01/07/2003 | US6504014 Tissue specific prodrug |
| 01/07/2003 | US6504005 Long-acting drugs and pharmaceutical compositions comprising them |
| 01/07/2003 | US6503982 Process for gelling aqueous media, use of copolyesters as gelling agents for aqueous media and new gelling copolyesters for aqueous media |
| 01/07/2003 | US6503955 Pourable liquid vehicle comprising polyoxyalkylene block copolymer, glycol and water; used to deliver compositions, materials, and substances to moistened surfaces and aqueous environments |
| 01/07/2003 | US6503940 Prodrugs for antimicrobial amidines |
| 01/07/2003 | US6503927 Amorphous paroxetine composition |
| 01/07/2003 | US6503918 D-mannitol and its preparation |
| 01/07/2003 | US6503911 Administering a sustained release pharmaceutical dosage form including ranolazine for therapy of cardiovascular disease selected from arrhythmias, variant and exercise-induced angina, and myocardial infarction |
| 01/07/2003 | US6503894 Pharmaceutical composition and method for treating hypogonadism |
| 01/07/2003 | US6503886 Gene delivery; polypeptide conjugated to fibroblast growth factor fused to nucleic acid |
| 01/07/2003 | US6503881 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |